You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives final approval for Amitriptyline Hydrochloride Tablets

Capital Market 

From USFDA

Zydus Cadila has received the final approval from the USFDA to market Amitriptyline Hydrochloride Tablets USP in strengths of 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, October 07 2017. 16:12 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU